BridgeBio Inc. seeks a Skeletal Dysplasia Account Manager for the Cincinnati region to lead the launch of Infigratinib, a first‑in‑class therapy for achondroplasia, partnering with providers and families to drive access and outcomes.
The ideal candidate has 8–10 years in pharma/biotech with rare disease experience, willingness to travel, and a proven track record in product launches and account management, collaborating across cross‑functional teams in the US.
#J-18808-LjbffrRemote Skeletal Dysplasia Account Manager - Launch Leader in cincinnati at Unknown Company
This position is listed as full time and onsite.